News
GlobalData on MSN8h
Sarepta share price drops again after third gene therapy deathSarepta Therapeutics’ share price has fallen again following the death of a third patient dosed with its gene therapy treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback